These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35464718)

  • 21. Redox-responsive prodrug for improving oral bioavailability of paclitaxel through bile acid transporter-mediated pathway.
    Lu X; Wu H; Liang Y; Zhang Z; Lv H
    Int J Pharm; 2021 May; 600():120496. PubMed ID: 33746013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy.
    Chen D; Ge S; Zuo L; Wang S; Liu M; Li S
    Drug Deliv; 2020 Dec; 27(1):1094-1105. PubMed ID: 32706289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual Stimuli-Responsive Polymer Prodrugs Quantitatively Loaded by Nanoparticles for Enhanced Cellular Internalization and Triggered Drug Release.
    Huang M; Zhao K; Wang L; Lin S; Li J; Chen J; Zhao C; Ge Z
    ACS Appl Mater Interfaces; 2016 May; 8(18):11226-36. PubMed ID: 27100328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acid-responsive endosomolytic polymeric nanoparticles with amplification of intracellular oxidative stress for prodrug delivery and activation.
    Lu N; Xi L; Zha Z; Wang Y; Han X; Ge Z
    Biomater Sci; 2021 Jun; 9(13):4613-4629. PubMed ID: 34190224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel drug delivery systems.
    Zhang Z; Mei L; Feng SS
    Expert Opin Drug Deliv; 2013 Mar; 10(3):325-40. PubMed ID: 23289542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of polymer-paclitaxel conjugate linked via a disulfide bond.
    Yan Q; Yang Y; Chen W; Hu J; Yang D
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():580-5. PubMed ID: 26478347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer.
    Wu J; Wang Q; Dong X; Xu M; Yang J; Yi X; Chen B; Dong X; Wang Y; Lou X; Xia F; Wang S; Dai J
    Theranostics; 2021; 11(8):3710-3724. PubMed ID: 33664857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers.
    Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
    Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained Codelivery of Cisplatin and Paclitaxel via an Injectable Prodrug Hydrogel for Ovarian Cancer Treatment.
    Shen W; Chen X; Luan J; Wang D; Yu L; Ding J
    ACS Appl Mater Interfaces; 2017 Nov; 9(46):40031-40046. PubMed ID: 29131563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.
    Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE
    ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomedicine-based paclitaxel induced apoptotic signaling pathways in A562 leukemia cancer cells.
    Wang Y; Zhou L; Xiao M; Sun ZL; Zhang CY
    Colloids Surf B Biointerfaces; 2017 Jan; 149():16-22. PubMed ID: 27716527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance.
    Wang S; Tan X; Li S; Zhou Y; Geng P; Hua A; Deng A; Yu Z
    Oncotarget; 2017 Dec; 8(67):111281-111294. PubMed ID: 29340053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pH-Sensitive Polymeric Micellar System Based on Chitosan Derivative for Efficient Delivery of Paclitaxel.
    Han Y; Pan J; Liang N; Gong X; Sun S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-Stimuli-Responsive Polymeric Prodrug for Enhanced Cancer Treatment.
    Wang Y; Shen N; Sakurai K; Tang Z
    Macromol Biosci; 2019 Dec; 19(12):e1900329. PubMed ID: 31747119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
    Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidation and Reduction Dual-Responsive Polymeric Prodrug Micelles Co-delivery Precisely Prescribed Paclitaxel and Honokiol for Laryngeal Carcinoma Combination Therapy.
    Zhou L; Wu J; Sun Z; Wang W
    Front Pharmacol; 2022; 13():934632. PubMed ID: 35935846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.